Pumping iron against cancer: exercise may protect muscle during chemo

NCT ID NCT05556239

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a supervised resistance training program could help lymphoma patients maintain muscle mass and physical function while undergoing chemotherapy. Forty-two adults with newly diagnosed lymphoma were randomly assigned to either the exercise program or usual care for 4 months. The main goal was to see if the training helped preserve lean body mass, with additional measures of walking speed, stair climbing, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
supervised resistance exercise training
What this could lead to
If effective, this training program could become a standard part of care to help lymphoma patients preserve muscle and physical function during chemotherapy.
What could go wrong
This is a small, single-center trial with only 42 participants, so results may not apply broadly. The intervention requires significant commitment and may not be feasible for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BODY COMPOSITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rigshospitalet

    Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.